[CLSTR]
< Back to situations

Monitor this situation.

[SITUATION] · [QUIET] · [BUSINESS]

2 clusters · 5 sources · 6 days · First seen · Last updated

Jeonnam-Gwangju AI vaccine manufacturing development

Overview

The Jeonnam-Gwangju region has secured 5 billion KRW in national funding to develop AI-driven technology for vaccine manufacturing and quality control. Led by GC Biopharma, the project will utilize mRNA-LNP production infrastructure at the Hwasun plant to implement real-time quality management through artificial intelligence.

In collaboration with Mokpo National University, Daegu Catholic University, and the Jeonnam Bio Promotion Agency, the initiative aims to analyze manufacturing process variations and establish predictive models for purification. The research and development program, which is part of a larger 7.6 billion KRW effort scheduled through 2030, seeks to strengthen the bio-industry ecosystem within the Hwasun Bio Special Zone.

Entities

GC Biopharma · Ministry of Trade, Industry and Energy · Daegu Catholic University · Jeonnam-Gwangju · Jeonnam Gwangju Integrated Special City

Timeline

  1. 18 days ago

    [BUSINESS] 2 sources
    Jeonnam Gwangju strengthens agricultural support and safety

    Jeonnam Gwangju Integrated Special City is offering up to 90% insurance premium support for autumn cabbage farmers and intensifying safety inspections for eco-friendly agricultural products.

  2. 23 days ago

    [TECHNOLOGY] 4 sources
    Jeonnam-Gwangju secures 5 billion KRW for AI vaccine quality control

    Jeonnam-Gwangju secured 5 billion KRW to develop AI-based quality control systems for mRNA vaccine manufacturing, led by GC Biopharma through 2030.

Sources

imaeil.com · jnilbo.com · namdonews.com · seoul.co.kr · womannews.net